Adding "hemodynamic and fluid leads" to the ECG. Part I: the electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation.

OBJECTIVES In primary care the diagnosis of CHF and ECF accumulation is no triviality. We aimed to predict plasma BNP, CHF and ECF accumulation with segmental impedance spectroscopy while using and extending the electrodes of the conventional electrocardiography. METHODS Three combined multiple electrodes were added to the 15 lead ECG for segmental impedance spectroscopy and for measuring the maximal rate of segmental fluid volume change with heart action at the thorax and the legs. The obtained signals were analyzed by partial correlation analyses in comparison with plasma BNP, CHF classes, ejection fraction by echocardiography and cardiac index by double gas re-breathing. 119 subjects (34 healthy volunteers, 50 patients with CHF, NYHA classes II to IV and 35 patients without CHF) were investigated. RESULTS The maximal rate of volume change with heart action at the thorax and at the legs, as well as the ECF/ICF ratio at the legs contribute equally and independently to the prediction of BNP and heart failure in an unknown test sample of 49 patients (multiple r=0.88, p<0.001). The ROC-curve for the predicted plasma BNP>400 pg/ml gave an AUC=0.93. The absence or the presence of heart failure could be predicted correctly by a binomial logistic regression in 92.9 and 87.5% of cases, respectively. CONCLUSION The methodology, which is based on inverse coupling of BNP release and of maximal blood acceleration and on sensitive detection of ECF overload, could enable the diagnosis of CHF with useful sensitivity and specificity while writing a routine-ECG.

[1]  B. Bruneau,et al.  BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. , 1997, The American journal of physiology.

[2]  G Pfurtscheller,et al.  A software package for non-invasive, real-time beat-to-beat monitoring of stroke volume, blood pressure, total peripheral resistance and for assessment of autonomic function. , 1998, Computers in biology and medicine.

[3]  R. Dennis Cook,et al.  Cross-Validation of Regression Models , 1984 .

[4]  B H Brown,et al.  Monitoring patients with left ventricular failure by electrical impedance tomography , 1999, European journal of heart failure.

[5]  U. Krämer,et al.  High frequency of diastolic dysfunction in a population-based cohort of elderly women - but poor association with the symptom dyspnea , 2011, BMC Geriatrics.

[6]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[7]  Kdoqi Disclaimer K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  L. Hatle How to diagnose diastolic heart failure a consensus statement. , 2007, European heart journal.

[9]  D. Oh,et al.  Association between Serum N-Terminal Pro-Brain Natriuretic Peptide Concentration and Left Ventricular Dysfunction and Extracellular Water in Continuous Ambulatory Peritoneal Dialysis Patients , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  B. Newman,et al.  Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up , 2005, Breast Cancer Research and Treatment.

[11]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  P. Poole‐Wilson,et al.  Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure. , 1998, QJM : monthly journal of the Association of Physicians.

[13]  R. Lindsay,et al.  Extravascular Lung Water and Peripheral Volume Status in Hemodialysis Patients With and Without a History of Heart Failure , 2006, ASAIO journal.

[14]  Generalizability of extracellular-to-intracellular fluid ratio using bio-impedance spectroscopy. , 2006, Physiological measurement.

[15]  Marianne Fenech,et al.  Total body water measurement by a modification of the bioimpedance spectroscopy method , 2006, Medical and Biological Engineering and Computing.

[16]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[17]  M. Berger,et al.  Segmental bioelectrical impedance analysis to assess perioperative fluid changes , 2000, Critical care medicine.

[18]  S. Heymsfield,et al.  Segment-specific resistivity improves body fluid volume estimates from bioimpedance spectroscopy in hemodialysis patients. , 2006, Journal of applied physiology.

[19]  J. Matthie Bioimpedance measurements of human body composition: critical analysis and outlook , 2008, Expert review of medical devices.

[20]  M. Gheorghiade,et al.  Serial evaluation of left ventricular function in congestive heart failure by measurement of peak aortic blood acceleration. , 1988, The American journal of cardiology.

[21]  T. Lüscher Diagnosis of CHF – Often a Trap in Itself , 2000 .

[22]  L. Ward,et al.  Quantitative bioimpedance spectroscopy for the assessment of lymphoedema , 2009, Breast Cancer Research and Treatment.

[23]  J. E. Snyder,et al.  Noninvasive Evaluation of Left Ventricular Performance Based on Peak Aortic Blood Acceleration Measured with a Continuous-Wave Doppler Velocity Meter , 1986, Circulation.

[24]  K. Leunissen,et al.  Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[26]  Hélène Morel,et al.  Measurements of body composition in limbs and trunk using a eight contact electrodes impedancemeter. , 2009, Medical engineering & physics.

[27]  Seoung Woo Lee,et al.  Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  M. Drazner,et al.  Correlation of impedance cardiography with invasive hemodynamic measurements in patients with advanced heart failure: the BioImpedance CardioGraphy (BIG) substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) Trial. , 2009, American heart journal.

[29]  Georgios Giannopoulos,et al.  NTproBNP: an important biomarker in cardiac diseases. , 2013, Current topics in medicinal chemistry.

[30]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[31]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[32]  S. Kusachi,et al.  Use of Plasma B-Type Natriuretic Peptide Level to Identify Asymptomatic Hypertensive Patients with Abnormal Diurnal Blood Pressure Variation Profiles: Nondippers, Extreme Dippers, and Risers , 2007, Hypertension Research.

[33]  C. Vorwerk,et al.  Thoracic electrical bioimpedance: a tool to determine cardiac versus non-cardiac causes of acute dyspnoea in the emergency department , 2010, Emergency Medicine Journal.

[34]  A. G. Warren,et al.  The Use of Bioimpedance Analysis to Evaluate Lymphedema , 2007, Annals of plastic surgery.

[35]  Rosario Scaglione,et al.  The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. , 2008, Journal of cardiac failure.

[36]  N. Levin,et al.  Estimation of normal hydration in dialysis patients using whole body and calf bioimpedance analysis , 2011, Physiological measurement.

[37]  D. Milzman,et al.  Thoracic impedance vs chest radiograph to diagnose acute pulmonary edema in the ED. , 2009, The American journal of emergency medicine.

[38]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  Sharon Zlochiver,et al.  Monitoring lung resistivity changes in congestive heart failure patients using the bioimpedance technique. , 2005, Congestive heart failure.

[40]  H. Krum,et al.  Meta-analysis: Effect of B-Type Natriuretic Peptide Testing on Clinical Outcomes in Patients With Acute Dyspnea in the Emergency Setting , 2010, Annals of Internal Medicine.

[41]  G. Parati,et al.  Transthoracic bioimpedance and brain natriuretic peptide levels accurately indicate additional diastolic dysfunction in patients with chronic advanced systolic heart failure , 2010, European journal of heart failure.

[42]  E. Facco,et al.  Relationship between central venous pressure and bioimpedance vector analysis in critically ill patients , 2000, Critical care medicine.

[43]  A. Piccoli,et al.  Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores. , 2002, Nutrition.

[44]  K. Wasserman,et al.  Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. , 2005, Journal of the American College of Cardiology.

[45]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[46]  R. Patterson,et al.  Fundamentals of impedance cardiography , 1989, IEEE Engineering in Medicine and Biology Magazine.

[47]  L. Tavazzi,et al.  “Peak Summation” Left Ventricular Filling Pattern in Patients with Chronic Heart Failure , 1998, Echocardiography.

[48]  S. Di Somma,et al.  Use of BNP and bioimpedance to drive therapy in heart failure patients. , 2010, Congestive heart failure.

[49]  Juerg Schwitter,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[50]  C. Lau,et al.  Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.

[51]  M. Elia,et al.  Bioelectrical impedance analysis--part I: review of principles and methods. , 2004, Clinical nutrition.

[52]  W. Tormey,et al.  B-type natriuretic peptide in the cardiology department. , 2012, Irish medical journal.

[53]  A. Azevedo,et al.  BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status. , 2010, International journal of cardiology.

[54]  Perry M. Elliott,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[55]  Hélène Morel,et al.  Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. , 2008, Medical engineering & physics.